AARD vs OMC · $284.4M cap vs rev $17.27B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
AARD currently screens at market cap $284.4M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the AARD and OMC stock pages for the full models.
Not investment advice.